HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predictors of prognosis in patients with peripartum cardiomyopathy.

AbstractOBJECTIVES:
To evaluate the long-term follow-up results of patients with peripartum cardiomyopathy and assess the echocardiographic findings relating to prognosis at time of diagnosis.
METHODS:
Thirty-three patients diagnosed with peripartum cardiomyopathy and hospitalized between 1995 and 2007 were analyzed. Initial echocardiographic data were recorded and long-term clinical status was evaluated.
RESULTS:
Eight (24%) patients recovered completely, 10 (30%) died, 2 (6%) underwent heart transplants, and 13 (39%) were left with persistent left ventricular dysfunction. Cut-off values for initial left ventricular end-systolic diameter (< or =5.5 cm) and left ventricular ejection fraction (>27%) were obtained from patients who had completely recovered.
CONCLUSION:
Cut-off values for initial left ventricular ejection fraction of >27% and left ventricular end-systolic diameter of < or =5.5 cm may predict recovery of left ventricle function.
AuthorsNilüfer Duran, Haci Günes, Ibrahim Duran, Murat Biteker, Mehmet Ozkan
JournalInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (Int J Gynaecol Obstet) Vol. 101 Issue 2 Pg. 137-40 (May 2008) ISSN: 0020-7292 [Print] United States
PMID18280479 (Publication Type: Journal Article)
Topics
  • Adult
  • Female
  • Follow-Up Studies
  • Heart Failure (diagnostic imaging, mortality, physiopathology)
  • Humans
  • Middle Aged
  • Pregnancy
  • Pregnancy Complications, Cardiovascular (diagnostic imaging, mortality, physiopathology)
  • Prognosis
  • Puerperal Disorders (diagnostic imaging, mortality, physiopathology)
  • ROC Curve
  • Recovery of Function (physiology)
  • Stroke Volume (physiology)
  • Survival Rate
  • Turkey
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: